4.55
price down icon2.57%   -0.12
 
loading
Precedente Chiudi:
$4.67
Aprire:
$4.42
Volume 24 ore:
30,197
Relative Volume:
1.28
Capitalizzazione di mercato:
$2.99M
Reddito:
$10.48M
Utile/perdita netta:
$-37.74M
Rapporto P/E:
-0.2811
EPS:
-16.1846
Flusso di cassa netto:
$-29.03M
1 W Prestazione:
-15.43%
1M Prestazione:
-68.40%
6M Prestazione:
-86.11%
1 anno Prestazione:
-95.91%
Intervallo 1D:
Value
$4.40
$4.61
Intervallo di 1 settimana:
Value
$4.40
$5.38
Portata 52W:
Value
$4.40
$540.00

Jaguar Health Inc Stock (JAGX) Company Profile

Name
Nome
Jaguar Health Inc
Name
Telefono
415-371-8300
Name
Indirizzo
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Name
Dipendente
49
Name
Cinguettio
@Jaguar_Health
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
JAGX's Discussions on Twitter

Confronta JAGX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
JAGX
Jaguar Health Inc
4.55 2.99M 10.48M -37.74M -29.03M -16.18
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 66.76B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-07-07 Iniziato Cantor Fitzgerald Overweight
2017-07-11 Iniziato Rodman & Renshaw Buy

Jaguar Health Inc Borsa (JAGX) Ultime notizie

pulisher
Apr 03, 2025

Jaguar Health outlines key Q2 2025 catalysts for crofelemer programs - MSN

Apr 03, 2025
pulisher
Apr 03, 2025

Jaguar Health (NASDAQ: JAGX) Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napo's FDA-Approved Drug Product - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 01, 2025

Jaguar Health completes $3.4 million private placement By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health completes $3.4 million private placement - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health CEO Leads $3.4M Strategic Investment Ahead of Key 2025 Catalysts - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health Advances Plant-Based Pharmaceuticals - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Jaguar Health’s Earnings Call: Growth Amid Challenges - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Jaguar Health sees revenue growth in Q4 2024 - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

JAGX stock plunges to 52-week low, touches $4.9 amid steep decline By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Jaguar Health sees revenue growth in Q4 2024 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

JAGX stock plunges to 52-week low, touches $4.9 amid steep decline - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023 - ACCESS Newswire

Mar 31, 2025
pulisher
Mar 31, 2025

Jaguar Health, Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 28, 2025

StockNews.com Begins Coverage on Jaguar Health (NASDAQ:JAGX) - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey - Weatherford Democrat

Mar 28, 2025
pulisher
Mar 28, 2025

83% of Oncologists Back Revolutionary Non-Antibiotic Treatment for Dogs with Cancer - Stock Titan

Mar 28, 2025
pulisher
Mar 27, 2025

Jaguar Health at Emerging Growth Virtual Conference: Strategic Catalysts Ahead - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Jaguar Health CEO, board members and investors invest in $3.448M bridge financing - MSN

Mar 27, 2025
pulisher
Mar 27, 2025

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study - ACCESS Newswire

Mar 27, 2025
pulisher
Mar 27, 2025

Mytesi Shows Promising Results in Breast Cancer: FDA to Review Game-Changing Phase 3 Data - Stock Titan

Mar 27, 2025
pulisher
Mar 26, 2025

Jaguar Health secures $3.448 million in convertible notes By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Sector Update: Health Care - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Jaguar Health secures $3.448 million in convertible notes - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts - galvnews.com

Mar 26, 2025
pulisher
Mar 26, 2025

Jaguar Health Executives Invest in $3.5 Million Bridge Financing; Shares Fall - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Jaguar Health Management Backs Company with Personal Investment in $3.4M Financing Deal - Stock Titan

Mar 26, 2025
pulisher
Mar 24, 2025

Upcoming Stock Splits This Week (March 24 to March 28) – Stay Invested - The Globe and Mail

Mar 24, 2025
pulisher
Mar 21, 2025

JAGX stock touches 52-week low at $0.21 amid sharp annual decline - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

JAGX stock touches 52-week low at $0.21 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 20, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Jaguar Health (NASDAQ:JAGX) Now Covered by StockNews.com - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

Jaguar Health initiates reverse stock split to meet Nasdaq standards By Investing.com - Investing.com Canada

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Health falls as it announces reverse stock split - MSN

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Health to Implement 1-for-25 Reverse Stock Split -March 18, 2025 at 09:05 am EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Animal Health Announces Reverse Stock Split - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Health initiates reverse stock split to meet Nasdaq standards - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Health, Inc. Announces Reverse Stock Split - ACCESS Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Health's Major 1:25 Reverse Split: Critical Move for Nasdaq Compliance - StockTitan

Mar 18, 2025
pulisher
Mar 17, 2025

Jaguar Health’s stock slammed after drug that aims to reduce gastro issues in cancer patients fails to meet trial goals - MSN

Mar 17, 2025
pulisher
Mar 13, 2025

Jaguar Animal Health Advances Crofelemer for Rare Diseases - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Jaguar Health Reports Approval of All Proposals at March 2025 Special Meeting of Stockholders - Jonesboro Sun

Mar 13, 2025
pulisher
Mar 13, 2025

Breakthrough: Jaguar Health's Cancer Drug Hits Phase 3 Targets, Rare Disease Trials Advance - Stock Titan

Mar 13, 2025
pulisher
Mar 11, 2025

JAGX stock touches 52-week low at $0.48 amid market challenges - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

JAGX stock touches 52-week low at $0.48 amid market challenges By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 06, 2025

Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates - ACCESS Newswire

Mar 06, 2025
pulisher
Mar 05, 2025

Jaguar Health Announces Completion of Third-party, Investigator-Initiated Study of Crofelemer, which is Expected to Support Orphan Drug Designation (ODD) for Crofelemer for Congenital Diarrheal Disorders (CDD) - ACCESS Newswire

Mar 05, 2025
pulisher
Mar 04, 2025

Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 - ACCESS Newswire

Mar 04, 2025

Jaguar Health Inc Azioni (JAGX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):